Cardiovascular outcomes of β‐blocker—calcium channel blocker initial dual therapy vs. other initial dual therapies in Chinese patients with hypertension: A real‐world retrospective study

Abstract This retrospective study compared cardiovascular (CV) outcomes between initial β‐blocker (BB) + calcium channel blocker (CCB) dual therapy (“B + C”) and other initial dual therapies in Chinese newly diagnosed hypertensive patients. In this study, all patients in a regional electronic databa...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Junxiong Lin, Qinghui Guo, Zhuoqiang Lu, Dajun Chai, Feng Peng, Jinxiu Lin
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Wiley 2023-05-01
Rangatū:	The Journal of Clinical Hypertension
Ngā marau:	β‐blocker calcium channel blocker hypertension initial dual therapy major adverse cardiovascular events
Urunga tuihono:	https://doi.org/10.1111/jch.14665
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!